Healthcare - Biotechnology - NASDAQ - US
$ 0.22
0 %
$ 940 K
Market Cap
-0.08
P/E
INCOME STATEMENT
3.77 M
REVENUE
-10.6 M
OPERATING INCOME
-10.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Histogen Inc.
| Revenue | 3.77 M |
| Cost Of Revenue | 0 |
| Gross Profit | 3.77 M |
| Operating Expenses | 14.3 M |
| Operating Income | -10.6 M |
| Other Expenses | 1 K |
| Net Income | -10.6 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 3.8 | 0.9 | 2.1 | 11.3 | 33.6 | 35.4 | 0.8 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 0 | 0.2 | 1.0 | 2.2 | 0 | 4 | 4 | 0 | 0 | 0 |
| Gross Profit | 3.8 | 0.7 | 1.1 | 9.1 | 33.6 | 35.4 | 0.8 | 0 | 0 | 0 |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 14.3 | 16.2 | 12.8 | 10.2 | 51.8 | 52.8 | 30.5 | 24.1 | 22.3 | 11.6 |
| Selling, General and Administrative Expenses | 9.4 | 7.8 | 6.6 | 6.2 | 10.4 | 9.6 | 10.2 | 7.8 | 7.4 | 4.7 |
| Research and Development Expenses | 5.0 | 8.5 | 6.2 | 4.1 | 41.4 | 43.2 | 20.3 | 16.3 | 14.9 | 6.9 |
| Operating Income | (10.6) | (15.5) | (11.7) | 0.9 | (18.3) | (17.6) | (29.8) | (24.1) | (22.3) | (15.6) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 1 K | 10 K | 64 K | 0 | 0.7 | 0.7 | 70 K | 70 K | 70 K | 0.5 |
| Total Other Income | 1 K | 0.4 | (7.1) | (1.9) | 0.3 | 0.2 | 98.3 K | 17.9 K | 0 | (4.0) |
| Pre-Tax Income | (10.6) | (15.0) | (18.8) | (3.0) | (18.0) | (17.4) | (29.7) | (24.1) | (22.3) | (15.6) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | (0.6) | 7.0 | 1.9 | 1.0 | 0.8 | 0.2 | 70 K | 70 K | 0.5 |
| Net Income | (10.6) | (14.4) | (25.8) | (4.9) | (18.0) | (17.4) | (29.7) | (24.1) | (22.3) | (15.6) |
| EPS | 3.46 | 7.51 | 57.2 | 8.29 | 119 | 122 | 263 | 1.3 | 1.44 | 2.12 |